Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001753926-25-000990·3i, LP
Schedule 13G ownership disclosure
PROCESSA PHARMACEUTICALS INC
Common Stock, par value $0.0001 per share · CUSIP: 74275C304
Event date: 2025-06-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 3i, LP
Shares: 1,681,944.00 · Class: 4.9%
- 3i Management LLC
Shares: 1,681,944.00 · Class: 4.9%
- Maier Joshua Tarlow
Shares: 1,681,944.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-000990
- Form type
- SCHEDULE 13G
- Filer
- 3i, LP
- CIK
- CIK 1841619
- Filed
- Jun 23, 2025
- Reporting period
- Jun 17, 2025
- Description
- Schedule 13G beneficial ownership